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Smoking cessation in heart failure: easier said than done: reply
We are thankful to Dr Lainscak and colleagues for their interest in our article on the association between smoking and clinical outcomes in patients hospitalized with heart failure. 1 Several key issues are raised about the findings from OPTIMIZE-HF that smokers hospitalized with heart failure had lower risk adjusted in-hospital mortality, shorter length of stay, and similar early post discharge mortality compared with nonsmokers. We concur that in addition to the variables included in our models, there are additional variables that, had they been adjusted for, may have strengthened or weakened the observed relationship between smoking status and clinical outcomes. A number of paradoxical associations between traditional cardiovascular risk factors (cholesterol, body mass index, and blood pressure) and clinical outcomes in patients with established heart failure have been previously reported by us and others. 2 The authors are in complete agreement that further studies are needed to confirm our findings before fully accepting that smoking represents another example of a paradoxical relationship in heart failure. Effective smoking cessation methods should be vigorously employed in individuals with heart failure, including those hospitalized. In OPTIMIZE-HF, only 62.8% of smokers were documented to have received smoking cessation counselling prior to discharge. 1 However, as previously reported, we did not find that smoking cessation counselling as documented by OPTIMIZE-HF participating hospitals was associated with improved post-discharge clinical outcomes. 3 Smoking cessation counselling in the hospital setting may range in intensity from a generic statement in discharge instructions to detailed individualized counselling with outpatient program referral. Smoking cessation counselling as currently provided to hospitalized heart failure patients may not be sufficient to result in maintenance of actual abstinence from smoking post-discharge. More intensive hospital-based counselling, use of nicotine replacement/suppression therapies, and referral to outpatient cessation programs may be required to achieve clinical benefits. Letters to the Editor diagnosed by MRI if patients had no signs of delayed enhancement typical for ischaemic heart disease or delayed enhancement patterns of myocarditis. Magnetic resonance imaging represents a powerful clinical tool for differentiating infarcted from normal (viable) myocardium and for characterizing the tissue pathology (necrosis, fibrosis, and oedema). Sub-endocardial or transmural myocardial delayed enhancement provides strong evidence of myocardial infarction but, when absent, it is not possible to distinguish tako-tsubo cardiomyopathy from a truly aborted myocardial infarction without myocardial necrosis. The features of ABS on cardiac MRI are myocardial oedema in the apical region in absence of necrosis, fibrosis, or scar formation. This 'pattern' of myocardial oedema is not typical for ABS: it also occurs in irreversibly injured myocardium, representing the marker of myocardium at risk of inflammation, or, in absence of late enhancement, it seems to be the magnetic resonance marker of myocardium 'at risk' of infarction that has been early reperfused and aborted. 2 The early spontaneous reperfusion of acute thrombotic occlusion of the coronary artery could be the explanation of a self-limiting ischaemic episode. In this case, in fact, myocardial necrosis is either absent or very small and myocardial delayed enhancement may not be demonstrated. Moreover, the typical tako-tsubo wall motion abnormalities may be seen in patients with acute myocardial infarction and myocardial delayed enhancement on MRI in the presence of only mild atherosclerosis in the coronary artery. The involvement of the entire apical segments could be explained by the presence of a large portion of stunned myocardium around the infarcted myocardium. 3 In a practical point of view, ABS may include a small number of patients with aborted myocardial infarction with typical apical ballooning pattern. Only a more accurate study of the left anterior descending coronary artery (i.e. with intravascular ultrasound or optical coherence tomography) is able to identify the presence of occult atherosclerotic plaques, not detected by conventional angiography. 3, 4 In conclusion, cardiovascular MRI may be useful in the assessment of ABS by demonstrating segmental dysfunction in the absence of myocardial irreversible damage (delayed enhancement) but, if myocardial delayed enhancement is absent, it may be difficult to distinguish ABS from a completely aborted myocardial infarction.
